These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8448324)

  • 1. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.
    Sobel JD; Vazquez J; Lynch M; Meriwether C; Zervos MJ
    Clin Infect Dis; 1993 Jan; 16(1):93-9. PubMed ID: 8448324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and susceptibility of Saccharomyces cerevisiae causing vaginitis in Greek women.
    Papaemmanouil V; Georgogiannis N; Plega M; Lalaki J; Lydakis D; Dimitriou M; Papadimitriou A
    Anaerobe; 2011 Dec; 17(6):298-9. PubMed ID: 21549212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Lynch ME; Sobel JD
    J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.
    Savini V; Catavitello C; Manna A; Talia M; Febbo F; Balbinot A; D'Antonio F; Di Bonaventura G; Celentano C; Liberati M; Piccolomini R; D'Antonio D
    Mycopathologia; 2008 Jul; 166(1):47-50. PubMed ID: 18443923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates.
    Posteraro B; Sanguinetti M; D'Amore G; Masucci L; Morace G; Fadda G
    J Clin Microbiol; 1999 Jul; 37(7):2230-5. PubMed ID: 10364590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method.
    McCullough MJ; Clemons KV; Farina C; McCusker JH; Stevens DA
    J Clin Microbiol; 1998 Feb; 36(2):557-62. PubMed ID: 9466776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.
    Arzeni D; Del Poeta M; Simonetti O; Offidani AM; Lamura L; Balducci M; Cester N; Giacometti A; Scalise G
    Eur J Epidemiol; 1997 Jun; 13(4):447-50. PubMed ID: 9258552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
    Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
    Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy.
    Singh S; Sobel JD; Bhargava P; Boikov D; Vazquez JA
    Clin Infect Dis; 2002 Nov; 35(9):1066-70. PubMed ID: 12384840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccharomyces cerevisiae vaginitis: transmission from yeast used in baking.
    Nyirjesy P; Vazquez JA; Ufberg DD; Sobel JD; Boikov DA; Buckley HR
    Obstet Gynecol; 1995 Sep; 86(3):326-9. PubMed ID: 7651635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saccharomyces cerevisiae vaginitis: microbiology and in vitro antifungal susceptibility.
    Echeverría-Irigoyen MJ; Eraso E; Cano J; Gomáriz M; Guarro J; Quindós G
    Mycopathologia; 2011 Sep; 172(3):201-5. PubMed ID: 21424705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.
    Barchiesi F; Arzeni D; Compagnucci P; Di Francesco LF; Giacometti A; Scalise G
    Med Mycol; 1998 Dec; 36(6):437-40. PubMed ID: 10206757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occurrence and the sensitivity to drugs of fungi other than Candida albicans isolated from the vagina].
    Pawlik B; Liber Z; Jurkowska E
    Med Dosw Mikrobiol; 1989; 41(1):60-6. PubMed ID: 2668661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
    Salonen JH; Richardson MD; Gallacher K; Issakainen J; Helenius H; Lehtonen OP; Nikoskelainen J
    J Hosp Infect; 2000 Aug; 45(4):293-301. PubMed ID: 10973747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Saccharomyces cerevisiae vaginitis].
    García-Martos P; Hernández JM; Mira J; Galán F; Marín P
    Enferm Infecc Microbiol Clin; 1996; 14(7):453-4. PubMed ID: 8991448
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
    Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
    J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.